Member Info for DRB83

Apologies chaps if that is the case. I must have missed that bit. Not interested in a takeover happening regardless as there is still so much value to be unlocked here. It's been bumpy but we're just at the start. It will smooth out once we move solely away from covid.

A vast fortune is relative to the person and their exposure so impossible to know if one will be made or not. In 2-3 years most of us will expect to be 10 fold from where we are today. If you have the nerve to hold then fortunes will be made.

Interesting, very interesting. Basically, we bought a lottery ticket and won the jackpot with Hamersley

EH - So 4moz JORC of which 3moz is left as my understanding is when this was being mined Silver was around $5/Oz so $20m in total. No wonder they stopped.

So the 3m Oz hasn't gone anywhere however we now expect there to be hell of a lot more in the surrounding areas. So at 10m Oz at $30oz gives us $300m. Someone correct me because this quick calculation makes our Hamersley tenement look astronomical. Have I missed something. Feels like we need $100/Oz to make this big. Thoughts please?

Given that we have discussed many times and arrived at, that a buyer would have to stump up at least the highest price of the last 12 months, wouldn't it make more sense to buy what you can on the open market at 250-400 say and then make an offer for the rest around 1200. This could make their average about 900-1000. £700m for a company churning over £40-60m EBITDA per annum. That would be good value based on today but we all know the real value of ncyt lies in its future potential. Bags of potential. At 1200 there is only one party getting a good deal and it won't be us. Ncyt needs time to flourish and realise it's potential. Then we'll discuss TO prices. Right now it is us who should be doing the Takeovers.

An interesting document.

Extract##
This week, a DHSC spokesperson claimed the Immensa lab was “fully accredited by the UK’s independent accreditation service (Ukas) before being appointed,” but Ukas quickly made clear it had never accredited Immensa nor its sister company, Dante Labs.

On Friday, the UKHSA said it had previously been incorrect to say the problem started on 8 September, and that it had actually arisen six days earlier.
####

These are the guys running the show. Put on the spot with a question they don't know the answer to so instead of finding out they just guess and hope it's right. It's often wrong.

Extract####
With UK cases running high, McNally said it may make sense to drop PCR testing in favour of lateral flow tests. “Why continue to use this huge amount of taxpayers’ money to provide PCR tests for an infection that the government is doing nothing to control? It makes zero sense,” he said. “We can use the enormous testing budget for something that might make a difference, such as supporting people who need to isolate.”
#####

Oh dear, I was kind of agreeing with him until he was sick in his mouth and spat that out. I guess I put it down to emotions running high.

One day we'll have a system that works. Until then, fend for yourselves.

I believe the reason TP have not issued a revised valuation is because it would put their low case around 4 bags from where we are today and their best case about 10 bags away.

From memory, the low case was approx £40m and best case £82m.

They still need to apply the 41% uplift in ownership of Hamersley.
They still need to reduce the 80% risk factor. Even a small 10% revision would have a decent impact on the valuation.
They then need to uplift the potential of Han**** as the range was 5-15mt. That is more likely to double.
Pretty sure the estimated grade was in the 50's also

It will certainly be interesting to see what they do arrive at.

Flu levels are thankfully low in the US with only 0.1% of positive cases from 100,000 tests. These tests have been conducted over a 2 week period.

It will be interesting to keep an eye on the level of testing for flu both in the UK and US. Winterplex can really come in to its own over the next few months but I guess only time will tell.

https://www.cdc.gov/flu/weekly/index.htm

Check out week 42, page 52. I believe it is trying to tell us that Flu hospital admissions is already higher than last winters peak.

https://www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season

Some interesting conspiracy theories being mentioned this past week about DA's arrival. Could Amryt have sent him in to prep Nova for a TO. Guess we'll find out before Xmas.

Neil, that is my understanding, that Co-prep compliments PROmate. Are we seeing any signs that Winterplex is going to be in demand this winter?

If people can't get a LFT for Day 2, what are the options:
1. Get a PCR (only slightly more expensive than LFT)
2. Cancel your holiday (highly unlikely)
3. Find a way to get round the system and don't even get a test but take the risk of a hefty penalty (not worth it)

I go with Option 1. Maybe PCR demand won't be as affected as we think.

Poidster, imo any dry powder should have been expensed at 250p. If this gets back above 3.50 over next couple of weeks then 250p will never be seen again. Imo the bargain price of 250 is long gone. Let's see.

Gteat questions Billy Boy. I would certainly like to hear the responses. They can't keep quiet for much longer regarding sales.

Bill needs to carefully manage his cash and ensure we firm up the fundamentals before the next placement is due. Upgrade Han****, possibly submit mining license application, drill results from EH, drill results at Brockman. After this point we will be well north of here and the placing will be 2p plus.

Happy for 5 days of steady 5% gains with an odd pull back by 5%. Sustain that for a week or 2 before big news lands that takes us back to the promised land. Good afternoon today. Long may it continue. I'm full loaded here so happy for the rise now. GLA

Oh and Corby forgot to factor in the capex of $30m so looks like we're going to just about break even on this $1b boys. Time to tell big Bill to wrap up and get out of there. Sorry guys just a little frustrating when people can't do the numbers.

So Jo will have to pay upto 1.45 to get his shares. He'll be wanting to at least double his money so 3p by next summer as an absolute minimum. Feels about right and not too rampy. That's about 4 bags from the recent bottom.

I believe he thinks the 90% or $270m is attributal to admin costs so I would just ignore the last comment. If people haven't got a clue then they should really ask or research before spouting it on here as if it has substance.

Reading PI100's message at 7:50 would likely lead potential new investors to believe that we have no presence at all in LFT.

It's always good to address the rather negative posts with a reminder that ncyt are very much in the LFT market as well as the PCR market, as well as the antibody market, as well as the variant market. So there is a clear link that the more cases increase the more revenue ncyt will be generating.

Whether that is reflected in the SP immediately is another thing entirely.

Going to mix it up a little with ResPlex and go for Antimicrobial RESistance. Non covid.